The Medido Monitored Compliance Device was recently featured in the Body & Soul liftout included in Sunday’s metropolitan paper. To read the article click here.

Following Cathie Reid’s Telstra Business Women’s Award win, Business Chicks sat down with Cathie to talk about her career, APHS and the future. To read more click here.

Cathie Reid named winner of the National Commonwealth Bank Business Owner Award category Cathie Reid, APHS Managing Partner, won the Commonwealth Bank Business Owner Award at the national Telstra Business Women’s Awards on Friday. After winning her category at the Queensland event, Cathie went on to take out the national prize above seven other exceptional [...]

View the latest APHS Circuit for relevant clinical information on: Postoperative nausea & vomiting Chemotherapy & hair loss Oral bowel cleansing solutions Brief on new drugs

APHS is delighted to have their Managing Partner, Cathie Reid, named a winner at the Queensland Telstra Business Women’s Awards on Tuesday. Cathie won the Commonwealth Bank Business Owner Award, where she was competing against five other exceptional Queensland finalists. Cathie’s win and acceptance speech acknowledged the role APHS plays in meeting Australia’s ageing population. [...]

APHS is delighted to announce Cathie Reid, APHS Managing Partner, has been named a finalist in the Queensland Telstra Business Women’s Awards for 2011.  “This is not just a public endorsement of my work, it is recognition of the entire APHS team who have worked so hard to deliver a business that is growing beyond [...]

  We are pleased to announce that APHS has been awarded the tender for pharmacy services at Port Macquarie Base Hospital (PMBH) on the New South Wales North Coast. A 171 bed hospital, with plans for significant growth, APHS has been contracted to supply a full service including oncology pharmacy. This is an outstanding result, which puts [...]

Please view APHS News for all the latest updates.

Over the last couple of years APHS has developed a growing presence in the oncology sector. This is the direct result of an internal strategy we have been building under our ICON division (Integrated Clinical Oncology Network). The first phase of this strategy was to establish ourselves as a preeminent provider of pharmacy services for [...]

Sanofi-aventis Australia Pty Ltd is initiating a recall of Lasix High Dose Solution for infusion 250mg/25ml. For more details on batch recalls please read the following recall statement.